InRetail Peru stock highlights Q3 growth as El Niño risks rise
Published on 11/17/2026 at 00:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly growth meets supply risks
- InRetail expanded food retail and shopping mall activity in the third quarter, while pharmacy growth remained positive.
- Management is bringing forward inventory purchases to protect stores against possible logistics disruptions linked to El Niño.
- Higher foreign-exchange, financing and depreciation costs weighed on net income.
InRetail Peru is bringing forward inventory purchases after warning that El Niño could disrupt roads and access to products. The company reported third-quarter revenue of PEN 6.261 billion, up 11.6% year over year, while net income fell 16.7% to PEN 201 million. The figures were reported with the quarterly results on November 12, 2026, and the supply measures were detailed in a November 15 report by Gestión.
Inventory moves target logistics risks
InRetail's pharmacy business, which includes Inkafarma and Mifarma, made advance purchases during the third quarter. Food Retail plans similar purchases in the fourth quarter for Plaza Vea, Vivanda, Mass and Makro. Chief Financial Officer Marcelo Ramos said the main operational exposure from El Niño would be supply-chain interruptions, including road blockages and difficulties accessing individual products.
Management said Food Retail continued to grow at a double-digit pace in October and November, while pharmacy sales were near 10%. The comments point to continued demand, but they also place logistics execution and inventory discipline at the center of the outlook.
Segment growth offsets cost pressure
Food Retail revenue reached PEN 3.575 billion, an increase of 15.1% from a year earlier. Pharmacy revenue rose 5.2% to PEN 2.433 billion, while Real Plaza revenue advanced 15.9% to PEN 217 million. Adjusted EBITDA increased 8.8% to PEN 831 million, although higher foreign-exchange effects, financing costs and depreciation reduced reported net income.
Food Retail's adjusted EBITDA margin narrowed to 8.4% from 9.2% in the year-earlier quarter. Management expects the margin to remain relatively stable in 2027 compared with the end of 2026, while the company continues to expand pharmacy and discount-store formats.
Peruvian retail platform
InRetail operates food retail, pharmacy and shopping mall businesses in Peru. Its food formats include supermarkets, discount stores and cash-and-carry outlets, while its pharmacy operations include Inkafarma and Mifarma. The company also operates the Real Plaza shopping mall portfolio and is headquartered in Lima.
InRetail Peru at a glance
- Company: InRetail Peru
- ISIN: US4578361028
- Headquarters: Lima, Peru
- Third-quarter revenue: PEN 6.261 billion
- Adjusted EBITDA: PEN 831 million
- Net income: PEN 201 million
- Business units: Food Retail, Pharma and Shopping Malls
Peruvian equities trade within the broader regional market environment covered in Current market reports.
